| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0267520285931239 | 0.18175898 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0267520285931239 | -0.32352898 |
| NSC 166199 | Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) | 0.0267520285931239 | 0.1418005 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0267520285931239 | -0.01653169 |
| NSC 295499 | Camptothecin Derivative | 0.0267520285931239 | 0.41379618 |
| NSC 330507 | Tanespimycin | 0.0267520285931239 | 0.10995758 |
| NSC 374980 | Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- | 0.0267520285931239 | 0.32230302 |
| NSC 649826 | Null | 0.0267520285931239 | 0.18836191 |
| NSC 650935 | 3,8-Dimethyl-1,2-naphthoquinone | 0.0267520285931239 | -0.10930147 |
| NSC 655905 | ANTINEOPLASTIC-655905 | 0.0267520285931239 | 0.037867506 |